Structural and Functional Characterization of MppR, an Enduracididine Biosynthetic Enzyme from Streptomyces hygroscopicus: Functional Diversity in the Acetoacetate Decarboxylase-like Superfamily
Abstract:The non-proteinogenic amino acid enduracididine is a critical component of the mannopeptimycins, cyclic glycopeptide antibiotics with activity against drug-resistant pathogens including methicillin-resistant Staphylococcus aureus. Enduracididine is produced in Streptomyces hygroscopicus by three enzymes, MppP, MppQ, and MppR. Based on primary sequence analysis, MppP and Q are pyridoxal-5'-phosphate-dependent aminotransferases; MppR shares low, but significant, sequence identity with acetoacetate decarboxylase.… Show more
“…[19] MppR shares ah igh degree of structurals imilarity with acetoacetate decarboxylase, which converts 1 to 3-[(4R)-2-iminoimidazolidin-4-yl]-2-oxopropanoic acid (2), the ketone form of l-End. [20] The PLP-dependenta minotransferase MppQ then catalyzes the reductivea mination of 2 to produce l-End ( Figure 5). Despite the different stereochemistry at C4, biosynthesis of l-allo-End in teixobactin may follow as imilarr oute to that of l-End.…”
Bacterial resistance to existing drugs is becoming a serious public health issue, urging extensive search for new antibiotics. Teixobactin, a cyclic depsipeptide discovered in a screen of uncultured bacteria, shows potent activity against all the tested Gram-positive bacteria. Remarkably, no teixobactin-resistant bacterial strain has been obtained despite extensive efforts, highlighting the great potential of teixobactin as a lead compound in the fight against antimicrobial resistance (AMR). This review summarizes recent progresses in the understanding of many aspects of teixobactin, including chemical structure, biological activity, biosynthetic pathway, and mode of action. We also discuss the different synthetic strategies in producing teixobactin and its analogues, and the structure-activity relationship (SAR) studies.
“…[19] MppR shares ah igh degree of structurals imilarity with acetoacetate decarboxylase, which converts 1 to 3-[(4R)-2-iminoimidazolidin-4-yl]-2-oxopropanoic acid (2), the ketone form of l-End. [20] The PLP-dependenta minotransferase MppQ then catalyzes the reductivea mination of 2 to produce l-End ( Figure 5). Despite the different stereochemistry at C4, biosynthesis of l-allo-End in teixobactin may follow as imilarr oute to that of l-End.…”
Bacterial resistance to existing drugs is becoming a serious public health issue, urging extensive search for new antibiotics. Teixobactin, a cyclic depsipeptide discovered in a screen of uncultured bacteria, shows potent activity against all the tested Gram-positive bacteria. Remarkably, no teixobactin-resistant bacterial strain has been obtained despite extensive efforts, highlighting the great potential of teixobactin as a lead compound in the fight against antimicrobial resistance (AMR). This review summarizes recent progresses in the understanding of many aspects of teixobactin, including chemical structure, biological activity, biosynthetic pathway, and mode of action. We also discuss the different synthetic strategies in producing teixobactin and its analogues, and the structure-activity relationship (SAR) studies.
“…Strukturell noch ungewöhnlicher sind die cyclischen Arg‐Analoga Enduracididin (End), bekannt von Mannopeptimycin, sowie das Capreomycidin (Cap), ein Bestandteil von Peptiden der Tuberactinomycin‐Gruppe wie des Viomycins. Für End wie auch für Cap (Schema a) wird Arg als Ursprung vorgeschlagen. Einiges deutet darauf hin, dass β‐Cyanalanin (Cya) ATP‐abhängig nach einem NRPS‐gebundenen Mechanismus durch Dehydratisierung aus Asn synthetisiert wird .…”
Section: Die Aminosäurebausteine – Grundlage Für Strukturelle Diversunclassified
Nicht‐ribosomale Peptidsynthetasen (NRPSs) sind große Multienzymmaschinerien, die zahlreiche Peptide mit enormer struktureller und funktionaler Diversität erzeugen. Unter diesen Produkten befinden sich mehr als 20 auf dem Markt befindliche Wirkstoffe, darunter Antibiotika (Penicillin, Vancomycin), antitumorale Medikamente (Bleomycin) und Immunsuppressiva (Cyclosporin). In den vergangenen Jahrzehnten haben biochemische sowie strukturbiologische Studien mechanistische Einblicke in die hochkomplexen NRPSs gewährt. Dieser Aufsatz fasst den aktuellen Kenntnisstand über die zugrundeliegenden Mechanismen von NRPSs zusammen und gibt einen Überblick über die Vielfalt ihrer Produkte. Ebenso behandelt werden die Probleme und Herausforderungen, die mit der Umprogrammierung von NRPS‐Systemen einhergehen. Das Potenzial einer solchen Umprogrammierung liegt begründet in einer nachhaltigen Generierung von Wirkstoffanaloga und neuen Substanzbibliotheken, die anderenfalls kaum zugänglich sind.
“…MppP is a PLP-dependent hydroxylase and catalyses the conversion of L-arginine ( 18 ) and molecular oxygen to 2-oxo-4-hydroxy-5-guanidinovaleric acid ( 20 , Scheme 1) [51]. The enzyme mppR is a pyruvate aldose that catalyses the dehydration/cyclisation of 20 to give cyclic guanidine 21 [52], where transamination by mppQ gives enduracididine ( 1 ). Further transformation to L-β-hydroxyenduracididine ( 5 ) is then catalysed by mppO [52–53].…”
Section: Reviewmentioning
confidence: 99%
“…The enzyme mppR is a pyruvate aldose that catalyses the dehydration/cyclisation of 20 to give cyclic guanidine 21 [52], where transamination by mppQ gives enduracididine ( 1 ). Further transformation to L-β-hydroxyenduracididine ( 5 ) is then catalysed by mppO [52–53]. …”
Rising resistance to current clinical antibacterial agents is an imminent threat to global public health and highlights the demand for new lead compounds for drug discovery. One such potential lead compound, the peptide antibiotic teixobactin, was recently isolated from an uncultured bacterial source, and demonstrates remarkably high potency against a wide range of resistant pathogens without apparent development of resistance. A rare amino acid residue component of teixobactin, enduracididine, is only known to occur in a small number of natural products that also possess promising antibiotic activity. This review highlights the presence of enduracididine in natural products, its biosynthesis together with a review of analogues of enduracididine. Reported synthetic approaches to the cyclic guanidine structure of enduracididine are discussed, illustrating the challenges encountered to date in the development of efficient synthetic routes to facilitate drug discovery efforts inspired by the discovery of teixobactin.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.